Fundamentals of Clinical Outsourcing Agenda at a Glance
DAY ONE PROGRAM AGENDA: Thursday, October 22, 2009
WORKSHOP:
| 8:30 | Workshop Registration & Morning Coffee
| 12:30 | Workshops Concludes; Luncheon for Workshop Participants
|
| 9:00 | Workshop Begins
| 1:00 | Registration for Main Conference Only Participants |
| 10:30 | 30-Minute Networking & Refreshment Break
| | |
For full workshop descriptions please click here.
WORKSHOP DETAILS: Contract Approach and Development: Key Terms and Negotiating Strategies Workshop Faculty Kathleen Greenough Manager Clinical Business Analysis, BIOGEN IDEC Donna Saligan, MBA, MT (ASCP) Senior Associate RH BOUCHARD & ASSOCIATES INC Michelle Rosen Corporate Counsel, VERTEX PHARMACEUTICALS INCORPORATED Who Should Attend This Workshop Pharmaceutical and Biotech Executives with roles in Outsourcing, Contracts, Procurement, Vendor Management |
DAY ONE PROGRAM AGENDA: Thursday, October 22, 2009
| 1:30 | Main Conference Begins - Chairperson’s Opening Remarks Rikki Hansen Bouchard President & CEO RH BOUCHARD & ASSOCIATES, INC. |
1:45 | Map the Clinical Development Outsourcing Process Graeme Currie, PhD Vice President, Clinical Operations SEPRACOR INC |
2:30 | Understand the Different Outsourcing Models Rikki Hansen Bouchard President & CEO RH BOUCHARD & ASSOCIATECIATES, INC. |
3:15 | 30-Minute Networking Break |
| 3:45 | Create a Corporate Outsourcing Strategy Anthony J. Carita Director, Clinical Outsourcing OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATIATION |
4:30 | KEYNOTE ADDRESS: Tracking the Transition from Transactional to Portfolio-Based Relationships Ken Getz, MBA Senior Research Fellow TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT |
| 5:15 | Day One Concludes |
DAY TWO PROGRAM AGENDA: Friday, October 23, 2009
7:45 | Morning Coffee |
8:15 | Chairperson’s Opening Remarks |
8:30 | The Benefits of a Establishing a Governance Committee David Reasner Senior Vice President, Clinical Operations and Data Analysis SEPRACOR INC |
9:15 | Relationship Management: The “Rules of Engagement” Larry Blankstein Senior Director, Clinical Research GENZYME Karen L. Wolf Senior Director, Clinical Operations MILLENNIUM PHARMACEUTICALS Shantal Feltham President and CEO STIRIS RESEARCH
|
10:00 | Networking & Refreshment Break |
10:30 | External Service Provider Identification, Assessment and Selection Heidi Shea Manager, BMRA Outsourcing GENZYME CORPORATIATION |
11:15 | Budget Basics and Outsourcing Tools and Content of Templates |
12:00 | Luncheon |
1:30 | Developing Scope of Work for a Solid Project Foundation and Minimal Project Setbacks Lynn McGovern Director, Strategic Sourcing MILLENNIUM PHARMACEUTICALS |
2:00 | Adhere to Timelines and other Measures of Success Lauren Goldsmith Senior Manager, Strategic Outsourcing MANNKIND CORPORATIATION |
| 2:30 | Refreshment and Networking Break |
3:00 | FDA ADDRESS: What Does FDA Expect Regarding Quality Oversight of Third Parties? Michael Marcarelli Director, Office of Bioresearch Monitoring, CDRH FDA |
| 3:45 | Conference Concludes |